# Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)

> **NCT01620554** · PHASE2 · COMPLETED · sponsor: **Bioprojet** · enrollment: 110 (actual)

## Conditions studied

- Obstructive Sleep Apnoea
- Excessive Daytime Sleepiness

## Interventions

- **DRUG:** BF2.649
- **DRUG:** BF2.649
- **DRUG:** BF2.649
- **DRUG:** BF2.649
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01620554
- **Lead sponsor:** Bioprojet
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2012-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01620554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01620554, "Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01620554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*